Literature DB >> 29143454

High Prevalence of Drug-Drug Interactions in Primary Health Care is Caused by Prescriptions from other Healthcare Units.

Marine L Andersson1, Ylva Böttiger2, Henrik Kockum3, Birgit Eiermann1.   

Abstract

Drug-drug interactions are increasingly common, as patients are getting older and the number of drugs per patient is increasing. In this study, we investigated to which extent potential drug-drug interactions originated from single or multiple prescribers. All patients attending any of 20 primary healthcare centres were included in a retrospective observational cohort study. Data on all prescriptions to these patients, irrespectively of the prescriber, were collected for two 4-month periods. Potential drug interactions were identified using the drug-drug interaction database SFINX. Interactions were classified with respect to the workplace of the prescriber, and the prevalence of interactions according to origin was analysed. We found that the drug interactions were significantly more common when the drugs were prescribed from different healthcare centres, compared with drugs prescribed from the patients' primary healthcare centre only. One explanation for this increased risk of drug interactions could be that the prescribers at different primary healthcare centres do not share the same information concerning the total medication list of the patient.
© 2017 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29143454     DOI: 10.1111/bcpt.12939

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  4 in total

1.  Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex® and Lexicomp®: a retrospective observational study.

Authors:  Afraa Abbas; Samaher Al-Shaibi; Sowndramalingam Sankaralingam; Ahmed Awaisu; Vyas S Kattezhathu; Supakit Wongwiwatthananukit; Yaw B Owusu
Journal:  Int J Clin Pharm       Date:  2021-11-23

2.  Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study.

Authors:  John E Hughes; Veronica Russo; Caroline Walsh; Enrica Menditto; Kathleen Bennett; Caitriona Cahir
Journal:  Drugs Aging       Date:  2021-10-11       Impact factor: 3.923

3.  The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan.

Authors:  Mohammad B Nusair; Sayer I Al-Azzam; Rasha M Arabyat; Haneen A Amawi; Karem H Alzoubi; Asma A Rabah
Journal:  Saudi Pharm J       Date:  2019-12-07       Impact factor: 4.330

4.  Polypharmacy is a risk factor for hospital admission due to a fall: evidence from the English Longitudinal Study of Ageing.

Authors:  P Zaninotto; Y T Huang; G Di Gessa; J Abell; C Lassale; A Steptoe
Journal:  BMC Public Health       Date:  2020-11-26       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.